ArticleCurrent medical imaging2025
The Long-term Volumetric and Radiological Changes of COVID-19 on Lung Anatomy: A Quantitative Assessment.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to assess the long-term volumetric and radiological effects of COVID-19 on lung anatomy. The severity of the disease was evaluated using radiological scoring, and lung volume measurements were performed
methodsA retrospective analysis was conducted on a total of 127 patients diagnosed with COVID-19 between April 2020 and December 2023. Initial and follow-up chest CT scans were reviewed to analyze lung volumes and radiological findings. Lung lobes were segmented using 3D Slicer software to measure volumes. Severity scores were assigned based on the Chung system, and statistical methods, including logistic regression and Wilcoxon signed-rank tests, were used to analyze outcomes.
resultsFollow-up CT scans showed significant improvements in lung volumes and severity scores. The left lung total volume increased significantly (p = 0.038), while right lung total volume and COVID-19-affected lung volumes demonstrated non-significant improvements. Severity scores and the number of affected lobes decreased significantly (p < 0.05). Correlation analyses revealed that age negatively influenced lung volume recovery (r = -0.177, p = 0.047). Persistent pathological findings, such as interstitial thickening and fibrotic bands, were observed.
conclusionCOVID-19 induces lasting changes in lung structure, particularly in elderly and severely affected patients. Long-term follow-up and the consideration of antifibrotic therapies are essential to manage post-COVID-19 complications effectively. A multidisciplinary approach is recommended to support patient recovery and minimize healthcare burdens.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.